Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
522.2 INR | +0.68% | +1.80% | +58.04% |
04-18 | Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US | MT |
04-17 | Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+58.04% | 540M | |
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |
- Stock Market
- Equities
- SHILPAMED Stock
- News Shilpa Medicare Limited
- Shilpa Medicare Gets Regulatory Nod for Pemetrexed Injections